Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 5
Submit an article Journal homepage
528
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Designing around patents with an immunotherapy case

A take-home message of a full court decision by the US Federal Circuit

Shyh-Jen Wang Division of Experimental Surgery; Department of Surgery; Taipei Veterans General Hospital; Institute of Hospital and Health Care Administration; National Yang-Ming University; TaiwanCorrespondence[email protected]
Pages 679-681 | Published online: 01 May 2012

References

  • Kimbery-Clark Corp. v. Johnson & Johnson. Federal Circuit Court of Appeals, 1984.
  • Elias S, Stim R. Patent, Copyright & Trademark. Berkeley, CA: Nolo, 2003.
  • Wang S-J. Designing around patents: a guideline. Nat Biotechnol 2008; 26:519 - 22; http://dx.doi.org/10.1038/nbt0508-519; PMID: 18464780
  • Wang S-J. Design-around biotechnology patents: an analysis of US Federal Circuit decisions shows the possibility of designing around biotechnology patents. Hum Vaccin 2011; 7:125 - 8; http://dx.doi.org/10.4161/hv.7.1.13943; PMID: 21263222
  • Phillips v. AWH Corp.: Federal Circuit Court of Appeals, 2005.
  • Abbott Laboratories v. Sandoz, Inc.: Federal Circuit Court of Appeals 2009.
  • Wang S-J, Wang S-Y. The verification flow chart of patent infringement. J Pat Trademark Off Soc 2004; 86:74 - 82
  • Pressman D. Patent it yourself. Berkeley, CA: Nolo.com, 2000.
  • TiVo, Inc. v. EchoStar Corp.: Federal Circuit Court of Appeals, 2010.
  • Additive Controls & Measurement Sys., Inc. v. Flowdata, Inc.: Federal Circuit Court of Appeals, 1998.
  • Abbott Labs. v. TorPharm, Inc.: Federal Circuit Court of Appeals, 2007.
  • California Artificial Stone Paving Co. v. Molitor. The US Supreme Court, 1885.
  • Arbek Mfg., Inc. v. Moazzam. Federal Circuit Court of Appeals, 1995.
  • Wang S-J. The obviousness rejection as a barrier to biotech patent prosecution. Nat Biotechnol 2009; 27:1125 - 6; http://dx.doi.org/10.1038/nbt1209-1125; PMID: 20010590
  • Afanasieva TA, Wittmer M, Vitaliti A, Ajmo M, Neri D, Klemenz R. Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy. Gene Ther 2003; 10:1850 - 9; http://dx.doi.org/10.1038/sj.gt.3302085; PMID: 12960975
  • Szalay A, Timiryasova T, Yu Y, Zhang Q. Microorganisms for therapy In: USPTO, ed. USA: Genelux Corporation, 2004.
  • Presta LG, Chen H, O’Connor SJ, Chisholm V, Meng YG, Krummen L, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997; 57:4593 - 9; PMID: 9377574
  • Fuh G, Gerber H, Liang W, Fellouse F, Sidhu S, Wiesmann C. Anti-VEGF antibodies. In: USPTO, ed. USA: Genentech, Inc., 2006.
  • State Indus. Inc. v. A.O. Smith Corp.: Federal Circuit Court of Appeals, 1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.